Geopolitics Alpha

FDA Launches Expedited IND Pilot, Begins Accepting Applications

Published . Updated .

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.

Directly affected

  • No company is named in this report.

Indirectly affected

  • ACHC ACADIA HEALTHCARE COMPANY INC

    GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

  • ASND ASCENDIS PHARMA A/S

    GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

  • ATYR ATYR PHARMA INC COM NEW

    GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

  • BBIO BRIDGEBIO PHARMA INC

    GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

  • DVA DaVita HealthCare Partners, Inc.

    GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

  • GEHC GE HEALTHCARE TECHNOLOGIES I

    GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
ACHC———————
ASND———————
ATYR———————
BBIO———————
DVA———————
GEHC———————

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.

Source: FDA

Price since this story was published: Acadia Healthcare (ACHC)

Since the first closing price after “FDA Launches Expedited IND Pilot, Begins Accepting Applications,” Acadia Healthcare (ACHC) is +7.30%. The S&P 500 fund (SPY) is +1.66% over the same days, a +5.64% difference versus the market.

ACHC
SPY

Who reported a Acadia Healthcare (ACHC) trade near this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Acadia Healthcare (ACHC)

Companies tied to this story

  • ACHC Acadia Healthcare

    In “FDA Launches Expedited IND Pilot, Begins Accepting Applications,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

  • ASND Ascendis Pharma A/S

    For “FDA Launches Expedited IND Pilot, Begins Accepting Applications,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

  • ATYR aTYR PHARMA

    aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence in the 15 Sep 2026 story “FDA Launches Expedited IND Pilot, Begins Accepting Applications.” Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

  • BBIO BridgeBio Pharma

    For “FDA Launches Expedited IND Pilot, Begins Accepting Applications,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

  • DVA Davita

    In “FDA Launches Expedited IND Pilot, Begins Accepting Applications,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

  • GEHC GE HealthCare Technologies

    GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence in the 15 Sep 2026 story “FDA Launches Expedited IND Pilot, Begins Accepting Applications.” Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

Acadia Healthcare (ACHC)

On 15 Sep 2026, “FDA Launches Expedited IND Pilot, Begins Accepting Applications” is the story that connects Acadia Healthcare (ACHC) to this story.

For Acadia Healthcare (ACHC), the reason on file says GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

A second company, Ascendis Pharma A/S (ASND), is listed for a different reason: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

Dates and price levels for Acadia Healthcare (ACHC)

ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. ATYR traded between 0.17 and 0.41 across 20 sessions. The latest close on file is 0.17.

What the saved facts support for Acadia Healthcare (ACHC)

46 out of 100

“FDA Launches Expedited IND Pilot, Begins Accepting Applications” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.